Adagio Medical Inc.
ADGM | NASDAQ
$0.48
-$0.02 (-4.57%)
Sep 22, 2026, 1:08 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 137K | 185K | 254K | 26K | 78K | 41K | 121K | 60K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 58K | 31K | 342K | 253K | 1.52M | 571K | 682K | 542K | 334K | 253K | 401K | 318K | 291K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -58K | -31K | -342K | -253K | -1.39M | -386K | -428K | -516K | -256K | -212K | -280K | -258K | -291K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.93M | -5.2M | -3.97M | -5.72M | -4.72M | -7.4M | -8.85M | -10.63M | -6.66M | -8.82M | -5.33M | -9.08M | -6.87M | -6.65M | -6.21M | -180.41K | -304.81K | -252.72K | -1.12M | -5.11M |
Interest Income | 72K | 107K | 132K | 79K | 102K | 164K | 753K | 166K | 2K | 1K | 1K | 2K | -1K | 1K | 4K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -6.72M | -7M | -3.31M | -10.12M | -3.95M | -7.71M | -57.37M | -4.63M | -5.73M | -8.02M | -9.14M | -10.76M | -7.93M | -9.28M | -6.03M | 564.82K | -196K | -211.19K | -1.1M | -5.09M |
Net Income | -6.72M | -7M | -3.31M | -10.12M | -3.95M | -7.71M | -57.37M | -4.63M | -5.73M | -8.02M | -9.14M | -10.76M | -7.93M | -9.28M | -6.03M | 564.82K | -196K | -211.19K | -1.1M | -5.09M |
Selling & General & Admin | 2.48M | 2.46M | 1.68M | 2.92M | 2.4M | 3.49M | 4.05M | 7.78M | 3.37M | 4.83M | 3.3M | 4.45M | 2.19M | 1.6M | 1.46M | 180.41K | 304.81K | 252.72K | 1.12M | 5.11M |
Research & Development | 2.45M | 2.74M | 2.24M | 2.77M | 1.97M | 3.66M | 3.42M | 2.47M | 2.87M | 3.47M | 1.77M | 4.42M | 4.41M | 4.8M | 4.45M | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.93M | 5.2M | 3.91M | 5.69M | 4.38M | 7.14M | 7.47M | 10.25M | 6.23M | 8.3M | 5.08M | 8.87M | 6.59M | 6.4M | 5.92M | 180.41K | 304.81K | 252.72K | 1.12M | 5.11M |
Interest Expense | 805K | 778K | 775K | 749K | 720K | 662K | n/a | 739K | 760K | 754K | 577K | 485K | 364K | 233K | 137K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 2.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.93M | 5.2M | 3.97M | 5.72M | 4.72M | 7.4M | 8.99M | 10.82M | 6.91M | 8.84M | 5.41M | 9.12M | 7M | 6.71M | 6.21M | 180.41K | 304.81K | 252.72K | 1.12M | 5.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 22.21M | 22.21M | 20.14M | 15.38M | 15.38M | 15.38M | 14.87M | 14.54M | 13.39M | 7.78M | 7.93M | 13.39M | 760.92K | 15.06M | 19.19M | 19.19M | 19.19M | 19.19M | 19.19M | 19.19M |
Shares Outstanding (Diluted) | 22.21M | 22.21M | 20.14M | 15.38M | 15.38M | 15.38M | 14.87M | 14.54M | 13.39M | 7.78M | 7.93M | 13.39M | 760.92K | 15.06M | 19.19M | 19.19M | 19.19M | 19.19M | 19.19M | 19.19M |
EPS (Basic) | -0.30 | -0.31 | -0.16 | -0.66 | -0.26 | -0.50 | -3.55 | -0.32 | -0.43 | -0.03 | -0.28 | -0.80 | -10.42 | -0.62 | -0.31 | 0.03 | -0.01 | -0.01 | -0.06 | -0.27 |
EPS (Diluted) | -0.30 | -0.31 | -0.16 | -0.66 | -0.35 | -0.50 | -3.55 | -0.32 | -0.43 | -0.03 | -0.28 | -0.80 | -10.42 | -0.62 | -0.31 | 0.03 | -0.01 | -0.01 | -0.06 | -0.27 |
EBITDA | -5.71M | -6.01M | -2.29M | -9.18M | -2.96M | -6.78M | -8.43M | -3.63M | -4.72M | -6.93M | -8.43M | -10.18M | -6.73M | -8.92M | -5.76M | -180.41K | -304.81K | -252.72K | -1.12M | -5.11M |
EBIT | -5.91M | -6.22M | -2.53M | -9.37M | -3.23M | -7.05M | -8.85M | -3.89M | -4.97M | -7.26M | -8.57M | -10.28M | -6.87M | -9.04M | -5.9M | -180.41K | -304.81K | -252.72K | -1.12M | -5.11M |
Depreciation & Amortization | 201K | 210K | 237K | 191K | 271K | 271K | 424K | 256K | 257K | 330K | 133K | 100K | 140K | 124K | 135K | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ADGM